SCHEMBL1453116

SCHEMBL1453116

C#CCCCC(C[CH2])OCC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1452857 0.80 — —
SCHEMBL4501820 0.77 DNM1 (0.33) —
SCHEMBL1454383 0.76 — —
SCHEMBL383685 0.75 OPRM1 (0.41) —
SCHEMBL1453025 0.74 USP2 (0.35) —
SCHEMBL5404538 0.74 OPRM1 (0.39) —
SCHEMBL9096924 0.74 LMNA (0.35) —
SCHEMBL2800518 0.72 — —
SCHEMBL2414769 0.71 — —
SCHEMBL1452941 0.71 TSHR (0.39) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7910617-B2 Method for suppressing the number of peripheral blood lymphocytes using an amino alcohol compound SANKYO COMPANY, LIMITED (JP) 2011-03-22 — — US disclosed
US-20070191468-A1 Amino alcohol compound DAIICHI SANKYO COMPANY, LIMITED (JP) 2007-08-16 — — US disclosed
EP-1733724-A1 AMINO ALCOHOL COMPOUND Sankyo Company, Limited (JP) 2006-12-20 — — EP disclosed
Send feedback